<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04550988</url>
  </required_header>
  <id_info>
    <org_study_id>POD10816</org_study_id>
    <nct_id>NCT04550988</nct_id>
  </id_info>
  <brief_title>Sonography and Haemophilia</brief_title>
  <official_title>Self-conducted Sonographic Monitoring of the Target Joints in Patients With Severe Haemophilia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swedish Orphan Biovitrum</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the possibility of establishing a patient-based&#xD;
      ultrasound monitoring of the knee (representing a target joint accessible with any hand) with&#xD;
      a handheld device:&#xD;
&#xD;
      The following questions will be answered:&#xD;
&#xD;
        1. What is necessary for the organisational implementation of a patient-based ultrasound&#xD;
           monitoring in patients with haemophilia?&#xD;
&#xD;
        2. Is it possible to train patients with haemophilia to perform sonography of their target&#xD;
           joints?&#xD;
&#xD;
        3. Does a patient-based ultrasound monitoring with a handheld device work in a home&#xD;
           setting?&#xD;
&#xD;
        4. What is the quality of the patient's self-acquired ultrasound images?&#xD;
&#xD;
        5. Will the test persons be able to distinguish normal findings from (any) pathologic&#xD;
           findings?&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 8, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Landmarks of the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol - Anterior mid-sagittal ultrasound image</measure>
    <time_frame>5 min</time_frame>
    <description>The patients will perform an ultrasound of their left and right knee according to the HEAD-US protocol. The following ultrasonic image is needed: Anterior mid-sagittal ultrasound image.&#xD;
Patella, distal femur, suprapatellar recess, suprapatellar fat pad and prefemoral fat pad must be visible.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Landmarks of the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol - Anterolateral transverse ultrasound image</measure>
    <time_frame>5 min</time_frame>
    <description>The patients will perform an ultrasound of their left and right knee according to the HEAD-US protocol. The following ultrasonic image is needed: Anterolateral transverse ultrasound image.&#xD;
Patellofemoral joint, lateral parapatellar recess, lateral patellar retinaculum and lateral femoral condyle must be visible.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Landmarks of the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol - Transverse ultrasound image - Transverse ultrasound image</measure>
    <time_frame>5min</time_frame>
    <description>The patients will perform an ultrasound of their left and right knee according to the HEAD-US protocol. The following ultrasonic image is needed: Transverse ultrasound image.&#xD;
Medial facets of the trochlea, lateral facets of the trochlea and cartilage must be visible.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Landmarks of the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol - Coronal ultrasound image</measure>
    <time_frame>5 min</time_frame>
    <description>The patients will perform an ultrasound of their left and right knee according to the HEAD-US protocol. The following ultrasonic image is needed: Coronal ultrasound image.&#xD;
Medial meniscus, boundaries of the femur, boundaries of the tibia must be visible.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Sonography</condition>
  <condition>Haemophilia</condition>
  <arm_group>
    <arm_group_label>Adult patients with severe haemophilia A or B</arm_group_label>
    <description>Adult patients (≥ 18 years of age) suffering from severe haemophilia A or B&#xD;
No professional medical background&#xD;
Submitted written consent to participate in the study and to use their study related pseudonymised data</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>feasibility study</intervention_name>
    <description>The aim of this study is to evaluate the possibility of establishing a patient-based ultrasound monitoring of the knee (representing a target joint accessible with any hand) with a handheld device.</description>
    <arm_group_label>Adult patients with severe haemophilia A or B</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients (≥ 18 years of age) suffering from severe haemophilia A or B. Haemophilia is&#xD;
        an X-linked recessive genetic bleeding disease characterised by absence or deficiency of&#xD;
        factor VIII in haemophilia A or factor IX in haemophilia B. This can cause spontaneous&#xD;
        bleedings, particularly into joints. Joint bleedings initiate an inflammatory process&#xD;
        characterised by chronic synovitis that causes degeneration of the affected joints and&#xD;
        results in haemophilic arthropathy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (≥ 18 years of age) suffering from severe haemophilia A or B&#xD;
&#xD;
          -  No professional medical background&#xD;
&#xD;
          -  Submitted written consent to participate in the study and to use their study related&#xD;
             pseudonymized data&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients suffering from other bleeding diseases&#xD;
&#xD;
          -  Participants &lt; 18 years of age&#xD;
&#xD;
          -  Participants without written consent&#xD;
&#xD;
          -  Professional medical background&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Strauß, PD Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medicine of the University of Bonn</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andreas Strauß, PD Dr.</last_name>
    <phone>004922828714176</phone>
    <email>andreas.strauss@ukbonn.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Bonn</name>
      <address>
        <city>Bonn</city>
        <state>Northrhine Westfalia</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Strauß, PD Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Andreas Strauß, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>September 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Bonn</investigator_affiliation>
    <investigator_full_name>PD Dr. Andreas Strauß</investigator_full_name>
    <investigator_title>Specialist in orthopedics and trauma surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The publication of anonymous patient data is not allowed by informed consent.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

